These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9740154)

  • 1. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foscarnet crystal deposition and renal failure.
    Goldfarb DS; Coe FL
    Am J Kidney Dis; 1998 Sep; 32(3):519-20. PubMed ID: 9740173
    [No Abstract]   [Full Text] [Related]  

  • 3. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
    Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G
    AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380
    [No Abstract]   [Full Text] [Related]  

  • 4. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crescentic glomerulonephritis and crystals within glomerular capillaries in an AIDS patient treated with foscarnet.
    Trolliet P; Dijoud F; Cotte L; Cahen R; François B; Trepo C; Patricot LM
    Am J Nephrol; 1995; 15(3):256-9. PubMed ID: 7618652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 7. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient foscarnet-induced hypercalcaemia.
    Barba R; Gómez-Rodrigo J; Marco J; Espejo M; Mena D
    AIDS; 1998 Oct; 12(14):1930-1. PubMed ID: 9792397
    [No Abstract]   [Full Text] [Related]  

  • 10. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of CMV retinitis with intravitreal foscarnet].
    Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
    J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 14. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. FDA approves generic foscarnet sodium injection.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous foscarnet administration for treatment of cytomegalovirus retinitis.
    Greening JG
    J Intraven Nurs; 1994; 17(2):74-7. PubMed ID: 8064492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 18. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal foscarnet for cytomegalovirus retinitis in patients with AIDS.
    Ausayakhun S; Watananikorn S; Ngamtiphakorn S; Prasitsilp J
    J Med Assoc Thai; 2005 Jan; 88(1):103-7. PubMed ID: 15960227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestations of the acquired immunodeficiency syndrome.
    Wong BM
    Hawaii Med J; 1997 Oct; 56(10):285-7. PubMed ID: 9385747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.